PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 141 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $9,113,000 | -23.6% | 1,300,000 | 0.0% | 2.12% | -15.2% |
Q2 2021 | $11,934,000 | -5.6% | 1,300,000 | 0.0% | 2.50% | -4.2% |
Q1 2021 | $12,636,000 | -5.3% | 1,300,000 | 0.0% | 2.61% | +20.6% |
Q4 2020 | $13,338,000 | +19.9% | 1,300,000 | +18.0% | 2.17% | +116.6% |
Q3 2020 | $11,120,000 | +1052.3% | 1,102,073 | +1091.4% | 1.00% | +1198.7% |
Q2 2020 | $965,000 | -97.2% | 92,502 | -89.7% | 0.08% | -97.8% |
Q1 2019 | $34,911,000 | +24.3% | 900,000 | -34.8% | 3.46% | -2.6% |
Q4 2018 | $28,077,000 | -99.9% | 1,379,700 | +175.9% | 3.55% | -29.8% |
Q1 2018 | $34,025,000,000 | – | 500,000 | – | 5.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |